Effects of iron and desferrioxamine on Rhizopus infection
- 1 May 1990
- journal article
- research article
- Published by Springer Nature in Mycopathologia
- Vol. 110 (2) , 87-91
- https://doi.org/10.1007/bf00446996
Abstract
To investigate the association among iron, desferrioxamine, and a Rhizopus infection, the influence of iron and/or desferrioxamine on experimental mucormycosis in mice was examined. All mice pretreated with iron, desferrioxamine, or a combination of iron and desferrioxamine died within 5 days after the inoculation of R. oryzae. In the mice fungal lesions were observed in the brain which resembled human cerebral mucormycosis. By contrast, the mortality in the control mice with R. oryzae was 20% through the 3-week experimental period. Therefore, it was demonstrated that iron as well as desferrioxamine administration markedly promotes the growth of R. oryzae. The increased susceptibility to R. oryzae was considered to be due to increased serum iron in the animals pretreated with iron only; however, pretreatment with desferrioxamine did not affect the amount of serum ion. Thus, the data suggest that desferrioxamine acts as a siderophore to R. oryzae and exerts an adverse effect on mucormycosis. This study has shown that the presence of iron and desferrioxamine enhances the virulence and pathogenicity of R. oryzae by serving as a growth factor.Keywords
This publication has 18 references indexed in Scilit:
- THE ROLE OF DESFERRIOXAMINE IN DIALYSIS-ASSOCIATED MUCORMYCOSIS - REPORT OF 3 CASES AND REVIEW OF THE LITERATURE1988
- Fatal Rhizopus Infections in Hemodialysis Patients Receiving DeferoxamineAnnals of Internal Medicine, 1987
- Mucormycosis — A New Risk of Deferoxamine Therapy in Dialysis Patients with Aluminum or Iron Overload?New England Journal of Medicine, 1987
- Intestinal Mucormycosis in Hemodialysis Patients Following DeferoxamineAmerican Journal of Kidney Diseases, 1987
- Yersinia Hepatic Abscesses and Iron OverloadJAMA, 1987
- Experimental candidiasis in iron overloadMycopathologia, 1985
- Hydroxamate siderophore production by opportunistic and systemic fungal pathogensInfection and Immunity, 1983
- Microbial Iron CompoundsAnnual Review of Biochemistry, 1981
- Advances in the use of iron-chelating agents for the treatment of iron overload.1979
- Ocular and orbital phycomycosisSurvey of Ophthalmology, 1977